Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: A prospective study

International Urology and Nephrology

Volumn 44, Issue 5, 2012, Pages 1539-1548

  Pereira, André Barreto ^a   Teixeira, Antônio Lúcio ^a   Rezende, Nilton Alves ^a   Pereira, Regina Maria ^b   Miranda, Débora Marques ^c   Oliveira, Eduardo Araujo ^c   Teixeira, Mauro M ^a   Simões e Silva, Ana Cristina ^c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FUNDAÇÃO HOSPITALAR DO ESTADO DE MINAS GERAIS   (Brazil)

^c Faculdade de Medicina   (Brazil)

Author keywords

Renal function; Renal survival; Renal transplantation; Urinary cytokines

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; CADAVER KIDNEY; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; TREATMENT OUTCOME;

EID: 84867873702     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0176-2     Document Type: Article

References (44)

1. Abecassis M, Bartlett ST, Collins AJ et al (2008) Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol 3:471-480
2. Meier-Kriesche HU, Schold JD, Srinivas TR et al (2004) Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transpl 4:378-383
3. Singh R, Srivastava P, Srivastava A et al (2010) Matrix metalloproteinase (MMP-9 and MMP-2) gene polymorphisms influence allograft survival in renal transplant recipients. Nephrol Dial Transpl 25:3393-3401
4. Nankivell BJ, Borrows RJ, Fung CL et al (2003) The natural history of chronic allograft nephropathy. N Engl J Med 349:2326-2333
5. Mikhalski D, Wissing KM, Ghisdal L et al (2008) Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation 85:S3-S9
6. Goldfarb-Rumyantzev AS, Naiman N (2010) Genetic predictors of acute renal transplant rejection. Nephrol Dial Transpl 25:1039-1047
7. Dallman MJ (1995) Cytokines and transplantation: Th1/Th2 regulation of the immune response to solid organ transplants in the adult. Curr Opin Immunol 7:632-638
8. Hu H, Aizenstein BD, Puchalski A et al (2004) Elevation of CXCR3-binding chemokines in urine indicates acute renalallograft dysfunction. Am J Transpl 4:432-437
9. Hauser IA, Spiegler S, Kiss E et al (2005) Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG). J Am Soc Nephrol 16:1849-1858
10. Woltman AM, de Fijter JW, van der Kooij SW et al (2005) MIP-3alpha/CCL20 in renal transplantation and its possible involvement as dendritic cell chemoattractant in allograft rejection. Am J Transpl 5:2114-2125
11. Tatapudi RR, Muthukumar T, Dadhania D et al (2004) Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int 65:2390-2397
12. Yamada K, Hatakeyama E, Arita S et al (2003) Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system. Clin Exp Nephrol 7:238-242
13. Teppo AM, Honkanen E, Finne P et al (2004) Increased urinary excretion of alpha1-microglobulin at 6 months after transplantation is associated with urinary excretion of transforming growth factor-beta1 and indicates poor longterm renal outcome. Transplantation 78:719-724
14. Womer KL, Kaplan B (2009) Recent developments in kidney transplantation - a critical assessment. Am J Transpl 9:1265-1271
15. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
16. Souto MF, Teixeira AL, Russo RC et al (2008) Immune mediators in idiopathic nephrotic syndrome: evidence for a relation between interleukin 8 and proteinuria. Pediatr Res 64:637-642
17. Vasconcelos MA, Bouzada MC, Silveira KD et al (2011) Urinary levels of TGF beta-1 and of cytokines in patients with prenatally detected nephrouropathies. Pediatr Nephrol 26:739-747
18. Obeidat MA, Luyckx VA, Grebe SO et al (2011) Posttransplant nuclear renal scans correlate with renal injury biomarkers and early allograft outcomes. Nephrol Dial Transpl 26:3038-3045
19. Furness PN, Philpott CM, Chorbadjian MT et al (2003) Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates. Transplantation 76:969-973
20. Bellomo R, Kellum JA, Ronco C (2004) Defining acute renal failure: physiological principles. Intensive Care Med 30:33-37
21. Devarajan P (2007) Emerging biomarkers of acute kidney injury. Contrib Nephrol 156:203-212
22. Kozakowski N, Regele H (2009) Biopsy diagnostics in renal allograft rejection: from histomorphology to biological function. Transpl Int 22:945-953
23. Perico N, Cattaneo D, Sayegh MH et al (2004) Delayed graft function in kidney transplantation. Lancet 364:1814-1827
24. Cardoni RL, Prigoshin N, Tambutti ML et al (2005) Regulatory cytokines in the response to the allogeneic renal transplant. Medicina (B Aires) 65:54-62
25. Abbas AK, Lichtman AH (2003) Cytokines. In: Abbas AK, Lichtman AH (eds) Cellular and molecular immunology, 1st edn. Saunders W.B, St Louis, pp 243-274
26. Baer PC, Koziolek M, Fierlbeck W et al (2005) CCchemokine RANTES is increased in serum and urine in the early post-transplantation period of human renal allograft recipients. Kidney Blood Press Res 28:48-54
27. Kotsch K, Mashreghi MF, Bold G et al (2004) Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation 77:1866-1875
28. Oliveira JG, Xavier P, Neto S et al (1997) Monocytesmacrophages and cytokines/chemokines in fine-needle aspiration biopsy cultures: enhanced interleukin-1 receptor antagonist synthesis in rejection-free kidney transplant patients. Transplantation 63:1751-1756
29. Robertson H, Morley AR, Talbot D et al (2000) Renal allograft rejection: beta-chemokine involvement in the development of tubulitis. Transplantation 69:684-687
30. Sakai N, Wada T, Furuichi K et al (2002) p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis. Nephrol Dial Transpl 17:998-1004
31. Citterio F, Pozzetto U, Romagnoli J et al (2004) Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens. Transpl Proc 36:698-699
32. Smith SD, Wheeler MA, Lorber MI et al (2000) Temporal changes of cytokines and nitric oxide products in urine from renal transplant patients. Kidney Int 58:829-837
33. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Stallone G, Schena FP (1997) Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation 63:414-420
34. Prodjosudjadi W, Daha MR, Gerritsma JSJ et al (1996) Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection. Nephrol Dial Transpl 11:1096-1103
35. Dubinski B, Boratynska M, KopecW, Szyber P, Patrzalek D, Klinger M (2008) Activated cells in urine and monocyte chemotactic peptide-1 (MCP-1) - sensitive rejection markers in renal graft recipients. Transpl Immunol 18:203-207
36. Thorburn E, Kolesar L, Brabcova E et al (2009) CXC and CC chemokines induced in human renal epithelial cells by inflammatory cytokines. APMIS 117:477-487
37. Christensen PJ, Rolfe MW, Standiford TJ et al (1993) Characterization of the production of monocyte chemoattractant protein-1 and IL-8 in an allogeneic immune response. J Immunol 151:1205-1213
38. Al-Lamki RS, Wang J, Skepper JN et al (2001) Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Invest 81:1503-1515
39. Al-Lamki RS, Wang J, Vandenabeele P et al (2005) TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. FASEB J 19:1637-1645
40. Mengel M, Gwinner W, Schwarz A et al (2007) Infiltrates in protocol biopsies from renal allografts. Am J Transpl 7:356-365
41. Mannon RB, Sundar SK, Sanfilippo FP et al (1993) Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. The effects of high-dose methylprednisolone. Transplantation 56:1157-1162
42. Kerr PG, Nikolic-Paterson DJ, Lan HY et al (1994) Deoxyspergualin suppresses local macrophage proliferation in rat renal allograft rejection. Transplantation 58:596-601
43. Atkins RC (1995) Interleukin-1 in crescentic glomerulonephritis. Kidney Int 48:576-586
44. Grone HJ, Weber C, Weber KS et al (1999) Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J 13:1371-1383